CNC vs ELV
Centene Corporation and Elevance Health, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CNC | ELV |
|---|---|---|
| Revenue | $174.6B | $199.1B |
| Net income | $-6.7B | $5.7B |
| Gross margin | 8.1% | 89.4% |
| Net margin | −3.8% | 2.8% |
| Return on equity | −28.8% | 13.3% |
| Diluted EPS | −$13.53 | $25.21 |
| Dividend / share | — | $5.92 |
| Payout ratio | — | 27.0% |
| Free cash flow | $4.3B | $3.2B |
| Equity | $20.0B | $43.9B |
| Net debt / equity | −0.02× | 0.51× |
| Current ratio | 1.10× | 1.54× |
| Revenue CAGR 5y | 11.0% | 10.3% |
| Profit CAGR 5y | — | 4.4% |
CNC and ELV book revenue within 15% of each other, and CNC closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | CNC | ELV |
|---|---|---|
| FY2025 | $174.6B | $199.1B |
| FY2024 | $145.5B | $177.0B |
| FY2023 | $140.1B | $171.3B |
| FY2022 | $135.5B | $156.6B |
| FY2021 | $118.0B | $138.6B |
| FY2020 | $103.8B | $121.9B |
| FY2019 | $70.4B | $104.2B |
| FY2018 | $56.4B | $92.1B |
| FY2017 | $45.6B | $90.0B |
| FY2016 | $37.6B | $84.9B |
Net income by year
Bottom line
| Fiscal year | CNC | ELV |
|---|---|---|
| FY2025 | $-6.7B | $5.7B |
| FY2024 | $3.3B | $6.0B |
| FY2023 | $2.7B | $6.0B |
| FY2022 | $1.2B | $5.9B |
| FY2021 | $1.3B | $6.2B |
| FY2020 | $1.8B | $4.6B |
| FY2019 | $1.3B | $4.8B |
| FY2018 | $900.0M | $3.8B |
| FY2017 | $828.0M | $3.8B |
| FY2016 | $562.0M | $2.5B |
Advertisement
AdSense · Rectangle 336×280